Joshua Schwinn

Mr. Joshua Schwinn


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2026 in Pets
Verified
Journal Article
Open access
PDF file
ARAnna-Chiara Riedl
Anna-Chiara Riedl
KJKatharina Charlotte Jensen
Katharina Charlotte Jensen
KSKatja Schirl
Katja Schirl
IHInes Hoffmann
Ines Hoffmann
JSJoshua Schwinn
Joshua Schwinn
Heike Aupperle-LellbachHeike Aupperle-Lellbach
Heike Aupperle-Lellbach
This retrospective study provides an extensive evaluation of feline squamous cell carcinoma (SCC), comparing oral and cutaneous SCC, as well as different oral/cutaneous sites, with respect to sex, age, breed, and coat length. It was based on 4300 SCCs submitted to LABOKLIN GmbH & Co. KG from 2017 to 2023. No sex predisposition was identified. Affected cats were predominantly older (median age 13 years). SCC risk increased with age, although cats of very young age were also affected. Breed predispositions were not found. However, compared to non-pedigree cats, Persians, Norwegian Forest Cats, British Shorthairs (BSH), Chartreux, and Siamese cats showed a reduced risk, as did longhaired cats. The predominant sites were the oral cavity (41.0%, 1762/4300) and skin (35.8%, 1540/4300). Maine Coons, BSHs, Persians, and Norwegian Forest Cats, as well as longhaired cats, developed oral SCC more frequently. Intraoral, gingival (36.2%, 637/1762) and lingual (19.0%, 334/1762) SCC predominated. Common cutaneous sites included the pinnae (35.0%, 539/1540), unspecified head/neck regions (8.8%, 135/1540), and the nose (8.7%, 134/1540). Maine Coons and BSHs showed less auricular SCC; Sphynx had more on the trunk. These findings emphasise SCC as a crucial differential diagnosis for oral and cutaneous lesions, even in young cats.

20 May 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
JSJoshua Schwinn
Joshua Schwinn
KTKatrin Törner
Katrin Törner
CBChristoph Beitzinger
Christoph Beitzinger
RKRobert Klopfleisch
Robert Klopfleisch
Heike Aupperle-LellbachHeike Aupperle-Lellbach
Heike Aupperle-Lellbach
Datasets from 849 dogs ≤ 3 years of age were analysed retrospectively, considering breed, sex, anatomic sites, multiplicity, tumour diameter, grading, and immunohistochemistry by using IBM® SPSS Statistics (version 29.0.2.0). Danish–Swedish farm dogs (OR: 8.11, 95% CI 3.33–19.77, p < 0.001) and English Setters (OR: 6.68, 95% CI 3.20–13.97, p < 0.001) showed the highest odds ratios (ORs) compared to crossbreeds. German Shepherd Dogs showed lower ORs (OR: 0.05, 95% CI 0.007–0.364, p < 0.01). The most common sites affected in the young dogs were the trunk (39.2%), hind limbs (24.9%), head (10.1%), fore limbs (7.4%), and pinnae (5%). Patnaik grading revealed 330 grade I (35.7%), 580 grade II (62.8%), and 14 grade III MCTs (1.5%). Kiupel “low grade” was found in 903 MCTs (97%), and 21 MCTs were “high grade” (3%). The prevalence of grade I MCTs was higher in Boxers (48.0%, p < 0.05) and Pugs (67.9%, p < 0.01). Pinnal MCTs were mostly grade I (58.3%, p < 0.01). In 6% (n = 51), multilocalised MCTs were found, and Golden Retrievers (12.5%, p = 0.02) and Pugs (21.4%, p = 0.005) were more affected than crossbreeds. Out of 87 dogs, 20 showed a Ki-67 count above the cut-off as well as KIT staining pattern II. The findings warrant heightened vigilance in evaluating cutaneous lesions in young dogs and highlight similarities and differences compared to the general dog population. Analysis of survival data is required to evaluate how the findings translate into a clinical setting.

17 December 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
ASAnnika Spitzer
Annika Spitzer
Heike Aupperle-LellbachHeike Aupperle-Lellbach
Heike Aupperle-Lellbach
MSMartin Spitzer
Martin Spitzer
SWSilvia Weidle
Silvia Weidle
LALeonore Aeschlimann
Leonore Aeschlimann
SBSimone de Brot
Simone de Brot
The chromatin remodelling proteins DAXX and ATRX are key regulators of genome stability and epigenetic processes. Alterations in their expression have been associated with tumour stage and prognostic outcomes in various human cancer types, whereas their role in veterinary oncology has received little investigation to date. We analysed canine prostate and urinary bladder samples, including 18 prostate carcinomas (12 adenocarcinomas and 6 prostatic urothelial carcinomas), 10 non-malignant prostate tissues, 22 urinary bladder carcinomas, and 6 non-malignant bladder tissues. Nuclear expression of DAXX and ATRX was assessed using fully quantitative digital immunohistochemistry. Overall, DAXX exhibited consistently higher expression than ATRX across benign and malignant samples from the prostate and bladder. DAXX and ATRX expression demonstrated a positive correlation across all samples (ρ = 0.553, p < 0.05), suggesting coordinated regulation. They displayed organ-specific expression patterns: prostate carcinomas showed increased expression of DAXX compared with non-malignant prostate tissues (p < 0.05). In contrast, in the bladder, expression of DAXX and ATRX declined with increasing tumour grade (p < 0.05). Our findings provide new insights into the potential of DAXX and ATRX as biomarkers, offering new insights into their clinical relevance in dogs.